Through analysis of public data sets in the UALCAN cancer database, we found that YB1 had the highest expression in samples from TNBC, the most aggressive form of breast cancer, followed by HER2-positive breast cancer, and had the lowest expression in luminal-type breast cancer in the TCGA data set (Fig. 2b). This evidence concerns the gene ERBB2 and cancer.